Administration of Drugs by Nurse Endoscopists
Monday, 29 November 2010 13:07
In response to the recent issues relating to the administration of drugs by nurse endoscopists, the National Prescribing Centre have issued a table of legal mechanisms for drug administration. This can be accessed at:
Shared examples of good practice can also be submitted on:
There is a breakfast meeting for nurse endoscopists at the BSG annual conference on Thursday March 17th where these issues will be discussed with Jane Brown Director of Policy and Implementation at the National Prescribing Centre.
Pauline Hutson, Chair BSG Nurses and Associates Section
Message to all Nurse Endoscopists
Monday, 19 July 2010 09:24
Message to all Nurse Endoscopists
The range of procedures being undertaken by nurse endoscopists is extending to include more therapeutic interventions particularly at bowel screening colonoscopy. It is timely therefore to review the issues relating to the administration of opiates by nurse endoscopists. A BSGE working party chaired by Dr Miles Allison Consultant Gastroenterologist convened in June to address these issues. The intention was also to review current practice involving other drugs including polyp lifting solutions used for endoscopic mucosal resection (EMR). In addition to representative nurse endoscopists from across the UK the meeting was also attended by Jane Brown, Director of Policy and Implementation from the National Prescribing Centre, David Cressey Consultant Anaesthetist representing the Royal College of Anaesthetists, Rick Forbes-Young representing the Royal College of Nursing and Pauline Hutson Representing the Endoscopy Associates Group.
Statement on Entonox and Fitness to Drive
Tuesday, 06 July 2010 09:01
The BSGE has recently received an enquiry into the use of Entonox and fitness to drive. Entonox (50% nitrous oxide, 50% oxygen, manufactured by BOC) is mainly used in obstetric units and by the ambulance service, but its analgesic and sedative properties with rapid onset and offset make it a potentially attractive agent in patients having colonoscopy and it is already in use in many units. A number of publications in the 1990s showed that it is safe and effective, with reduced discomfort and nausea compared to IV agents and allows earlier discharge from the recovery unit. It is perhaps surprising that it is not more widely used.
As for the question of fitness to drive: the recently revised product licence states that patients are fit to drive a vehicle (or operate machinery) after only 30 minutes. Used in combination with a rapidly acting bowel cleansing agent, this could mean that for patients whose colonoscopy is to be done mid-week, only half a day away from work is required – a major advantage for the self-employed. A pdf file, "Entonox: Information for the User" is available from BOC (and on the BSG website)
Alistair McNair, Secretary BSG Endoscopy
- BOC Entonox Product Guide [ 44 Kb ]
Urgent Message to all Nurse Endoscopists
Friday, 22 January 2010 10:20
The issue of administering controlled drugs during colonoscopy by nurse endoscopists has recently been highlighted by the RCN. An investigation into the practice of obtaining a medical signature after administration of a controlled drug is currently under review and will result in disciplinary action. This is an illegal act and will therefore be dealt with accordingly. All nurse endoscopists must obtain a documented prescription prior to administering a controlled drug at any time during a colonoscopy procedure.
Further information may be found on the National Prescribing Centre's website:
Saturday, 14 March 2009 22:43
Gastrointestinal Nursing is published ten times a year. A UK annual subscription rate normally costs £82.00 (£54.00 for students). Subscribing securely through our website, however, will qualify you for a special website price of £69.00 (£50.00 for students) and ensure you get every issue of Gastrointestinal Nursing delivered regularly to your door.
Page 3 of 3